ClinConnect ClinConnect Logo
Search / Trial NCT05867173

Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces

Launched by MASSACHUSETTS EYE AND EAR INFIRMARY · May 17, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how cochlear implants, which are devices that help people with severe hearing loss, affect the way we hear speech. The researchers want to understand how these implants work in both children and adults, improve the ways cochlear implants are programmed, and see how quickly people adjust to new settings on their devices. By studying these factors, the aim is to enhance hearing outcomes for those who use cochlear implants.

To participate in this study, adults must be at least 18 years old and native speakers of American English, using specific models of cochlear implants. Children as young as 6 months old can also join if they meet similar language and device criteria. Participants will be involved in various tasks to help researchers gather important information about how cochlear implants can be optimized for better hearing. Overall, this study hopes to provide valuable insights that could lead to improved experiences for cochlear implant users.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Research Subjects with a Cochlear Implant ADULTS Inclusion Criteria
  • Adult at least 18 years old
  • Native speakers of American English
  • Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL
  • CHILDREN Inclusion Criteria
  • Children at least 6 months old
  • Native speakers of American English
  • Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL
  • For both children and adults with a cochlear implant, some study criteria might pertain to a subset of subjects, such as a specific age at which the subjects developed a hearing loss, or was implanted.
  • Exclusion Criteria:
  • Exclusion for all Cochlear Implant Subjects:
  • Inability to provide informed consent
  • Does not meet the inclusion criteria for a specific study protocol, such as age of onset of hearing loss, age of cochlear implantation, duration of deafness, number of active electrodes in the cochlear implant device
  • Unable to carry out the study protocol or tasks required in the study
  • Exclusion for all Normal Hearing Subjects:
  • Inability to provide informed consent
  • Hearing loss, or significant history of hearing related issues
  • Unable to carry out the study protocol or tasks required in the study

About Massachusetts Eye And Ear Infirmary

Massachusetts Eye and Ear Infirmary is a leading academic medical center specializing in the diagnosis and treatment of eye, ear, nose, and throat disorders. Affiliated with Harvard Medical School, the institution is renowned for its commitment to advancing clinical research and innovative therapies in ophthalmology, otology, and related fields. With a focus on improving patient outcomes, the infirmary conducts a variety of clinical trials aimed at enhancing understanding of diseases and developing cutting-edge treatment options. Its multidisciplinary team of experts collaborates closely with patients and research partners to ensure the highest standards of care and scientific integrity.

Locations

Waltham, Massachusetts, United States

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Julie Arenberg

Principal Investigator

Massachusetts Eye and Ear

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported